Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • Stack AI Reviews & Ratings
    33 Ratings
    Company Website
  • Valant Behavioral Health EHR Reviews & Ratings
    321 Ratings
    Company Website
  • RXNT Reviews & Ratings
    535 Ratings
    Company Website
  • ScriptSure Reviews & Ratings
    30 Ratings
    Company Website
  • Elation Health Reviews & Ratings
    85 Ratings
    Company Website
  • CredentialStream Reviews & Ratings
    161 Ratings
    Company Website
  • XpertCoding Reviews & Ratings
    41 Ratings
    Company Website
  • RegDesk Reviews & Ratings
    13 Ratings
    Company Website
  • AestheticsPro Reviews & Ratings
    628 Ratings
    Company Website
  • 3CX Reviews & Ratings
    1,170 Ratings
    Company Website

What is Genomenon?

Pharmaceutical firms need a wealth of genomic information to successfully execute precision medicine strategies; however, they often utilize only a fraction—around 10%—of the total data at their disposal for decision-making. Genomenon offers an extensive database to counter this limitation. Their Prodigy™ Patient Landscapes deliver a cost-effective and efficient approach for conducting natural history research, which is crucial for developing treatments for rare conditions by expanding the understanding of both past and future health data. Employing a sophisticated AI-driven process, Genomenon meticulously analyzes each patient referenced in the medical literature much faster than traditional methods. It is essential to capture all pertinent insights by examining every genomic biomarker highlighted in scholarly articles. Each scientific assertion is backed by solid evidence sourced from medical literature, enabling researchers to identify all genetic factors and pinpoint variants classified as pathogenic according to ACMG clinical criteria, thus streamlining the creation of targeted therapies. By adopting this thorough strategy, pharmaceutical companies can significantly boost their research efficiency and, in turn, enhance patient outcomes. This innovative model not only fosters advancements in drug development but also contributes to a deeper understanding of genetic influences on health.

What is Emedgene?

Emedgene enhances the processes associated with tertiary analysis in the fields of rare disease genomics and various germline research projects. The platform is designed to improve the speed and consistency of interpreting, prioritizing, curating, and producing research reports on user-defined variants. By utilizing explainable AI (XAI) and automation, Emedgene significantly increases efficiency across a range of analysis workflows, including genomes, exomes, virtual panels, and targeted panels. It also aids in merging laboratory operations and next-generation sequencing (NGS) instruments with IT systems, thereby optimizing and securing the entire workflow. As science and technology continue to evolve alongside growing demands, Emedgene provides users with the latest advancements through innovative knowledge graph features, curation tools, and expert assistance throughout their research endeavors. Additionally, laboratories can enhance their throughput without needing to hire extra personnel, thanks to the capabilities of XAI and automated systems. Ultimately, Emedgene supports the implementation of high-throughput workflows for whole genome sequencing (WGS), whole exome sequencing (WES), virtual panels, or targeted panels, all of which seamlessly integrate into the digital infrastructure of any laboratory. This holistic approach ensures that researchers can dedicate their efforts to uncovering new insights while benefiting from reliable technological support that evolves with their needs. By streamlining these complex processes, Emedgene empowers researchers to maximize their potential and drive impactful discoveries in genomics.

Media

Media

Integrations Supported

Google Cloud Platform
Illumina DRAGEN Secondary Analysis

Integrations Supported

Google Cloud Platform
Illumina DRAGEN Secondary Analysis

API Availability

Has API

API Availability

Has API

Pricing Information

Pricing not provided.
Free Trial Offered?
Free Version

Pricing Information

Pricing not provided.
Free Trial Offered?
Free Version

Supported Platforms

SaaS
Android
iPhone
iPad
Windows
Mac
On-Prem
Chromebook
Linux

Supported Platforms

SaaS
Android
iPhone
iPad
Windows
Mac
On-Prem
Chromebook
Linux

Customer Service / Support

Standard Support
24 Hour Support
Web-Based Support

Customer Service / Support

Standard Support
24 Hour Support
Web-Based Support

Training Options

Documentation Hub
Webinars
Online Training
On-Site Training

Training Options

Documentation Hub
Webinars
Online Training
On-Site Training

Company Facts

Organization Name

Genomenon

Company Location

United States

Company Website

www.genomenon.com/pharma/

Company Facts

Organization Name

Illumina

Company Location

United States

Company Website

www.illumina.com/products/by-type/informatics-products/emedgene.html

Categories and Features

Popular Alternatives

VSClinical Reviews & Ratings

VSClinical

Golden Helix

Popular Alternatives

VarSeq Reviews & Ratings

VarSeq

Golden Helix
Kanteron Reviews & Ratings

Kanteron

Kanteron Systems
Alissa Interpret Reviews & Ratings

Alissa Interpret

Agilent Technologies
QIAGEN CLC Genomics Workbench Reviews & Ratings

QIAGEN CLC Genomics Workbench

QIAGEN Digital Insights